Important Information

and 20th Anniversary Celebration
November 12-15, 2014
Realizing the Dream of Precision Medicine
With special address by Dr. Francis Collins

Corporate Workshop Day
November 12, 2014

Special Address by Dr. Francis Collins
November 12, 2014

Molecular Pathology Outreach Course
November 12, 2014

Exhibit Dates
November 13-15, 2014

Gaylord National Resort & Convention Center
National Harbor, MD
(Just outside Washington, DC)

Early (Reduced) Registration
September 10, 2014
Advance Registration
October 20, 2014
Hotel Reservations
October 20, 2014

How to Help

Corporate Support Opportunities
Donate to AMP


Linked In FaceBook Twitter
Project management using Podio


Clinical Practice Committee Working Groups
clinical practice committee

Clinical Practice Committee - Infectious Disease Working Group

The current focus for the Infectious Diseases Division of the Clinical Practice Committee is to work towards the normalization of quantitative nucleic acid amplification testing for analytes such as cytomegalovirus (CMV), Epstein-Barr virus (EBV) and BK virus, beginning with CMV.

CMV Working Group

The CMV Working Group is comprised of 64 AMP members with a uniform interest in standardizing CMV quantitation by PCR. This group was formed in the fall of 2003 under the leadership of Dr. Daynna Wolff. In 2004, Dr. Wolff, with the assistance of Dr. Paul Neuwald, coordinated a multicenter analysis which demonstrated that laboratories across the country using a wide variety of platforms performed similarly in terms of relative quantification from sample to sample. However, there was disparity in terms of absolute value.  The results of this project were presented at the 2004 Annual Meeting and are available in the AMP Web Library. The current focus of the group is to work with the National Institutes of Standards and Technologies (NIST) for the formation of a standard unit for CMV PCR, to which all labs can normalize their system.

For more information, contact: Kathleen Stellrecht, PhD